Top Immunotherapy Companies
7 Immunotherapy companies, sorted by total funding raised.
7
Companies
$308.1M
Combined Funding
Series A
Top Stage
Indexed tracks 7 Immunotherapy companies that have collectively raised $308.1M in documented funding. The most-funded immunotherapy companies tracked include Atara Biotherapeutics and Dispatch Biotherapeutics. Series A is the most common funding stage among immunotherapy companies in this dataset.
Clinical-stage allogeneic T-cell immunotherapy company developing off-the-shelf cell therapies fo...
Clinical-stage immunotherapy company developing the Flare platform to expand curative potential o...
Clinical-stage biotech pioneering in vivo mRNA-based multi-immune programming; rebranded as CREAT...
Immunotherapy company developing next-generation TCR-based therapeutics for cancer treatment.
R&D company with 3 SBIR/STTR awards from National Science Foundation, Department of Health and Hu...
Barinthus Biotherapeutics plc is a clinical-stage biopharmaceutical company developing novel T ce...
Marker Therapeutics is dedicated to the development and commercialization of next-generation T ce...
Frequently Asked Questions
How many Immunotherapy companies are tracked on Indexed?
Indexed tracks 7 Immunotherapy companies, sorted by total funding raised.
How much funding have Immunotherapy companies raised in total?
The Immunotherapy companies tracked by Indexed have collectively raised $308.1M in documented funding.
What are the top-funded Immunotherapy companies?
The most-funded Immunotherapy companies tracked include Atara Biotherapeutics, Dispatch Biotherapeutics, Myeloid.
Explore More
Other Industries